🇺🇸 FDA
Patent

US 9096501

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

granted A61PA61P3/10A61P35/00

Quick answer

US patent 9096501 (Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P3/10, A61P35/00, A61P9/10